Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains

Megan C. Rich, Chesleigh N. Keene, Miriam D. Neher, Krista Johnson, Zhao Xue Yu, Antoine Ganivet, V. Michael Holers, Philip F. Stahel

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains'. Together they form a unique fingerprint.

Medicine & Life Sciences